Athens, Greece, February 19, 2026 RTsafe is proud to announce that its core innovation, the PseudoPatient®, has received official Medical Device Marketing Authorization (MDMA-2-2026-0352) from the Saudi Food & Drug Authority (SFDA). This important regulatory milestone enables RTsafe to market and distribute PseudoPatient across the Kingdom of Saudi Arabia and represents a significant step forward […]

Athens, Greece / Brisbane, Australia – December 15, 2025  RTsafe, a leading medical technology company specialising in quality assurance (QA) solutions for radiation therapy, and Icon Group (Icon), a leading integrated cancer care provider with a global reach across Australia, New Zealand, ASEAN, Mainland China and the United Kingdom, today announced the purchase of two RTsafe PRIME phantoms. These are the first PRIME phantoms to […]

Athens, Greece / Pavia, Italy — December 11, 2025 RTsafe is delighted to announce a new partnership with CNAO Next s.r.l., the services and innovation arm of Fondazione CNAO, to jointly deliver independent proton and carbon-ion dosimetry audits for hadron therapy centers around the world. Through this partnership, RTsafe will extend its certified dosimetry services […]